Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients. [electronic resource]
Producer: 20110912Description: 189-95 p. digitalISSN:- 1462-0332
- Adolescent
- Antibodies, Monoclonal -- adverse effects
- Antirheumatic Agents -- adverse effects
- Arthritis, Juvenile -- drug therapy
- Biological Products -- adverse effects
- Child
- Cohort Studies
- Etanercept
- Female
- Humans
- Immunoglobulin G -- adverse effects
- Male
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Registries
- Time Factors
- Treatment Outcome
- Tumor Necrosis Factor Inhibitors
- Tumor Necrosis Factors -- adverse effects
- United Kingdom
- Withholding Treatment
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.